Patents Assigned to Otologic Pharmaceuticals, Inc.
  • Formulations of n-acetylcysteine and uses thereof
    Patent number: 11020354
    Abstract: Disclosed herein are compositions comprising a first compound that is N-acetylcysteine or a salt thereof, optionally a second compound that is a pharmaceutically acceptable compound capable of forming a radical adduct; and a coating layer encapsulating at least the first compound. Also disclosed are methods of use and manufacture.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: June 1, 2021
    Assignee: Otologic Pharmaceuticals, Inc.
    Inventor: Richard E. Gammans